GoAI
Get started
China Traditional Chinese Medicine Holdings Co. Limited logo

China Traditional Chinese Medicine Holdings Co. Limited

0570.HK

HKSEHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Latest quote

HK$1.38

−HK$0.01 · -0.72%

Aug 24, 2:00 PM HKT

0570.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
HK

Market position

Day range

Current HK$1.38

52-week range

Current HK$1.38

Open
HK$1.38
Previous close
HK$1.39
Volume
6.42M
Market cap
6.95B HKD
50-day average
HK$1.4258
-3.21% below average
200-day average
HK$1.834
-24.75% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
7.9B CNY
P/E (TTM)
-17.4×
P/B (TTM)
0.29×
P/S (TTM)
0.4×
EV / EBITDA
5.19×
Earnings yield
-3.62%
Free cash flow yield
20.70%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
48.09%
Operating margin
-1.82%
Net margin
-2.32%
Return on equity
-1.67%
Return on assets
-1.06%
Return on invested capital
-1.00%

Financial health

Debt / equity
0.12×
Current ratio
2.29×
Altman Z-score
2.2
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends69%43%17%-9%Gross margin, FY2021: 62.09%Gross margin, FY2022: 50.32%Gross margin, FY2023: 51.18%Gross margin, FY2024: 47.59%Gross margin, FY2025: 48.09%Operating margin, FY2021: 14.45%Operating margin, FY2022: 7.44%Operating margin, FY2023: 7.88%Operating margin, FY2024: 2.03%Operating margin, FY2025: -1.82%Net margin, FY2021: 10.14%Net margin, FY2022: 5.34%Net margin, FY2023: 7.09%Net margin, FY2024: 0.33%Net margin, FY2025: -2.32%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 62.09%. Gross margin FY2022 50.32%. Gross margin FY2023 51.18%. Gross margin FY2024 47.59%. Gross margin FY2025 48.09%. Operating margin FY2021 14.45%. Operating margin FY2022 7.44%. Operating margin FY2023 7.88%. Operating margin FY2024 2.03%. Operating margin FY2025 -1.82%. Net margin FY2021 10.14%. Net margin FY2022 5.34%. Net margin FY2023 7.09%. Net margin FY2024 0.33%. Net margin FY2025 -2.32%.

Income trends

Revenue

14.74B CNY-10.69%

Operating income

−268.9M CNY−604.5M CNY

Net income

−342.07M CNY−396.14M CNY
Income trends across reported periods20.99B CNY13.23B CNY5.48B CNY−2.28B CNYRevenue, FY2021: 19.05B CNYRevenue, FY2022: 14.3B CNYRevenue, FY2023: 18.12B CNYRevenue, FY2024: 16.51B CNYRevenue, FY2025: 14.74B CNYOperating income, FY2021: 2.75B CNYOperating income, FY2022: 1.06B CNYOperating income, FY2023: 1.43B CNYOperating income, FY2024: 335.59M CNYOperating income, FY2025: −268.9M CNYNet income, FY2021: 1.93B CNYNet income, FY2022: 764.49M CNYNet income, FY2023: 1.29B CNYNet income, FY2024: 54.07M CNYNet income, FY2025: −342.07M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 19.05B CNY. Revenue FY2022 14.3B CNY. Revenue FY2023 18.12B CNY. Revenue FY2024 16.51B CNY. Revenue FY2025 14.74B CNY. Operating income FY2021 2.75B CNY. Operating income FY2022 1.06B CNY. Operating income FY2023 1.43B CNY. Operating income FY2024 335.59M CNY. Operating income FY2025 −268.9M CNY. Net income FY2021 1.93B CNY. Net income FY2022 764.49M CNY. Net income FY2023 1.29B CNY. Net income FY2024 54.07M CNY. Net income FY2025 −342.07M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue14.74B CNY16.51B CNY18.12B CNY14.3B CNY19.05B CNY
Cost of goods sold7.65B CNY8.65B CNY8.85B CNY7.11B CNY7.22B CNY
Gross profit7.09B CNY7.86B CNY9.27B CNY7.2B CNY11.83B CNY
Research and development511.47M CNY596.01M CNY685.63M CNY611.83M CNY694.44M CNY
Selling, general, and administrative6.07B CNY6.48B CNY7.45B CNY5.55B CNY8.56B CNY
Operating expenses7.36B CNY7.52B CNY7.85B CNY6.13B CNY9.12B CNY
Interest income34.65M CNY47.68M CNY65.26M CNY67.27M CNY62.58M CNY
Interest expense103.34M CNY235.77M CNY199.05M CNY220.7M CNY222.03M CNY
Depreciation and amortization1.07B CNY1.07B CNY1.13B CNY1.1B CNY849.6M CNY
Operating income−268.9M CNY335.59M CNY1.43B CNY1.06B CNY2.75B CNY
Net income−342.07M CNY54.07M CNY1.29B CNY764.49M CNY1.93B CNY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-0.05

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.20.10-0.09Q3 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q3 '25Q1 '26
Q3 2022, reported Aug 26, 2022: actual 0.096, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 24, 2023: actual 0.079, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 29, 2023: actual 0.124, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 21, 2024: actual 0.155, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 28, 2024: actual 0.045, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 25, 2025: actual -0.033, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 29, 2025: actual -0.023, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 20, 2026: actual -0.052, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates25.51B18.97B12.43B5.89BQ3 '22No estimateQ1 '23MissQ3 '23MissQ1 '24MissQ3 '24No estimateQ1 '25No estimateQ3 '25No estimateQ1 '26No estimate
Q3 2022, reported Aug 26, 2022: actual 6.92B HKD, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 24, 2023: actual 9.5B HKD, estimate 22.36B HKD, surprise -57.52%, Miss. Q3 2023, reported Aug 29, 2023: actual 10.05B HKD, estimate 22.3B HKD, surprise -54.92%, Miss. Q1 2024, reported Mar 21, 2024: actual 9.76B HKD, estimate 24.13B HKD, surprise -59.56%, Miss. Q3 2024, reported Aug 28, 2024: actual 9.01B HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 25, 2025: actual 8.64B HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 29, 2025: actual 8.18B HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 20, 2026: actual 8.1B HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.1123

2019 complete year+34.7% since 2017

Corporate action history

Dividend

Ex-dividend Jul 3, 2025

HK$0.0865

Special

Record Jul 4, 2025 · Payment Jul 18, 2025

Dividend

Ex-dividend Jun 2, 2023

HK$0.0518

Annual

Record Jun 6, 2023 · Payment Jun 20, 2023

Dividend

Ex-dividend Jun 29, 2022

HK$0.0736

Annual

Record Jun 30, 2022 · Payment Jul 29, 2022

Dividend

Ex-dividend Sep 2, 2021

HK$0.0666

Annual

Record Sep 6, 2021 · Payment Oct 20, 2021

Dividend

Ex-dividend Jun 24, 2020

HK$0.0476

Annual

Record Jun 27, 2020 · Payment Jul 13, 2020

Dividend

Ex-dividend Sep 2, 2019

HK$0.0572

Semi-Annual

Record Sep 3, 2019 · Payment Oct 16, 2019

0570.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$197.8

-3.89%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.74

-3.03%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$222.4

-2.46%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.60

-4.71%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.22

-5.62%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$100.2

-2.15%

ETFs holding 0570.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard FTSE Emerging Markets ETF logoVanguard FTSE Emerging Markets ETFVWO
Market value
9.28M
Weight
0.01%
AUM
162.3B USD
Expense ratio
0.06%
Price / 1D
$60.45+0.72%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
9.04M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.71+0.78%
iShares Core MSCI Emerging Markets ETF logoiShares Core MSCI Emerging Markets ETFIEMG
Market value
5.87M
Weight
0.00%
AUM
160B USD
Expense ratio
0.09%
Price / 1D
$81.57+0.64%
Avantis Emerging Markets Equity ETF logoAvantis Emerging Markets Equity ETFAVEM
Market value
4.48M
Weight
0.02%
AUM
27.89B USD
Expense ratio
0.33%
Price / 1D
$94.24+0.75%
Vanguard FTSE All-World ex-US ETF logoVanguard FTSE All-World ex-US ETFVEU
Market value
1.4M
Weight
0.00%
AUM
95.9B USD
Expense ratio
0.04%
Price / 1D
$85.69+0.82%
iShares Core MSCI Total International Stock ETF logoiShares Core MSCI Total International Stock ETFIXUS
Market value
713.3K
Weight
0.00%
AUM
60.91B USD
Expense ratio
0.07%
Price / 1D
$97.945+0.76%
Schwab Emerging Markets Equity ETF logoSchwab Emerging Markets Equity ETFSCHE
Market value
692.34K
Weight
0.01%
AUM
12.89B USD
Expense ratio
0.06%
Price / 1D
$36.97+0.71%
Dimensional - Emerging Markets Core Equity 2 ETF logoDimensional - Emerging Markets Core Equity 2 ETFDFEM
Market value
676K
Weight
0.01%
AUM
9.49B USD
Expense ratio
0.39%
Price / 1D
$39.93+0.50%

Continue in GoAI

Research 0570.HK

research.disclaimer